Biased β-agonists may provide better control of asthma and other obstructive lung diseases, drug discovery study shows
A USF Health-led team tests 40 million compounds and finds lead candidate that selectively relaxes airway smooth muscle cells with no detectable drug desensitization TAMPA, Fla. (Dec. 2, […]
USF drug discovery study identifies promising new compound to open constricted airways
Experts in airway bitter taste receptors and medicinal chemistry team up to advance a potential asthma and COPD treatment that works differently than existing bronchodilators TAMPA, Fla (Jan […]
Compounds halt SARS-CoV-2 replication by targeting key viral enzyme
A University of Arizona-University of South Florida team identified and analyzed four promising antiviral drug candidates in the preclinical study TAMPA, Fla. (July 6, 2020) — As the […]
Scientific community continues to respond in force to COVID-19 pandemic
From designing 3D printed test swabs, to researching antibody responses and engaging in leading clinical trials, USF Health scientists rapidly team up to help fight COVID-19 While the […]
David Kang probes brain changes in aging that tip the balance toward dementia
His team searches beyond the hallmark Alzheimer’s disease proteins for alternative treatments In his laboratory at the USF Health Byrd Alzheimer’s Center, neuroscientist David Kang, PhD, focuses on […]
Patients at center of 8th annual FARA-USF scientific symposium
Patients have always been the center of the yearly scientific symposium hosted by the Friedreich’s Ataxia Research Alliance (FARA) and the University of South Florida Ataxia Research Center. […]
USF researcher studying brain-eating parasite featured speaker at Amoeba Summit 2016
University of South Florida researchers continue to hone the high-volume screening of compounds that may lead to optimal drugs to combat the rare but deadly infection caused by […]
USF Health research on neuroprotective protein shifts to drug discovery with £875,000 Dementia Consortium project
New dementia drug discovery efforts get underway this month at the University of South Florida, Tampa, Fla., thanks to £875,000 funding (approximately $1.2 million) from the Dementia Consortium. […]
USF global health team pioneers development of new antimalarial drug screening model
Tampa, FL (Nov. 10, 2015) — A University of South Florida (USF) Center for Global Health & Infectious Diseases Research team has demonstrated a new screening model to […]
USF global health researchers play role in discovery of new antimalarial drug
Potent compound inhibits protein synthesis at various stages of malaria parasite’s life-cycle With the rapid emergence of multi-drug resistant strains of malaria, the need to find new drugs […]